Etiology of gastrointestinal bleeding in patients on dual antiplatelet therapy

Etiology of gastrointestinal bleeding in patients on dual antiplatelet therapy INTRODUCTIONAspirin and clopidogrel significantly reduce the risk of myocardial infarction (MI), stroke, vascular events or cardiovascular death compared with placebo. According to the current American College of Cardiology (ACC)/American Heart Association (AHA) guidelines, dual antiplatelet therapy (DAPT) is recommended after percutaneous coronary and peripheral vascular interventions, MI and ischemic stroke.However, these benefits are offset to some degree by an increased risk of bleeding, especially gastrointestinal (GI) bleeding. Several large randomized cardiovascular trials have confirmed the association of DAPT with an increased risk of GI bleeding compared with aspirin therapy alone. In patients undergoing percutaneous coronary intervention, GI bleeding is a common cause of non‐access site bleeding and has been associated with increased inpatient morbidity and mortality.However, while a plethora of large‐scale studies show the incidence, predictors and prognosis of DAPT‐related GI bleeding, there is a relative paucity of evidence on the etiology of such bleeding. This is mostly because these large randomized studies were performed to assess the effect of DAPT on cardiovascular outcomes, and GI bleeding was only one out of a large number of events that were recorded. These studies did not report on the etiology of GI bleeding, just on their incidences and severity. The available http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Digestive Diseases Wiley

Etiology of gastrointestinal bleeding in patients on dual antiplatelet therapy

Loading next page...
 
/lp/wiley/etiology-of-gastrointestinal-bleeding-in-patients-on-dual-antiplatelet-Dluu993wd1
Publisher
Wiley
Copyright
© 2018 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd
ISSN
1751-2972
eISSN
1751-2980
D.O.I.
10.1111/1751-2980.12575
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONAspirin and clopidogrel significantly reduce the risk of myocardial infarction (MI), stroke, vascular events or cardiovascular death compared with placebo. According to the current American College of Cardiology (ACC)/American Heart Association (AHA) guidelines, dual antiplatelet therapy (DAPT) is recommended after percutaneous coronary and peripheral vascular interventions, MI and ischemic stroke.However, these benefits are offset to some degree by an increased risk of bleeding, especially gastrointestinal (GI) bleeding. Several large randomized cardiovascular trials have confirmed the association of DAPT with an increased risk of GI bleeding compared with aspirin therapy alone. In patients undergoing percutaneous coronary intervention, GI bleeding is a common cause of non‐access site bleeding and has been associated with increased inpatient morbidity and mortality.However, while a plethora of large‐scale studies show the incidence, predictors and prognosis of DAPT‐related GI bleeding, there is a relative paucity of evidence on the etiology of such bleeding. This is mostly because these large randomized studies were performed to assess the effect of DAPT on cardiovascular outcomes, and GI bleeding was only one out of a large number of events that were recorded. These studies did not report on the etiology of GI bleeding, just on their incidences and severity. The available

Journal

Journal of Digestive DiseasesWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off